MDPI and ACS Style
Wachal, Z.; Bombicz, M.; Priksz, D.; Hegedűs, C.; Kovács, D.; Szabó, A.M.; Kiss, R.; Németh, J.; Juhász, B.; Szilvássy, Z.;
et al. Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone. Int. J. Mol. Sci. 2020, 21, 2124.
https://doi.org/10.3390/ijms21062124
AMA Style
Wachal Z, Bombicz M, Priksz D, Hegedűs C, Kovács D, Szabó AM, Kiss R, Németh J, Juhász B, Szilvássy Z,
et al. Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone. International Journal of Molecular Sciences. 2020; 21(6):2124.
https://doi.org/10.3390/ijms21062124
Chicago/Turabian Style
Wachal, Zita, Mariann Bombicz, Dániel Priksz, Csaba Hegedűs, Diána Kovács, Adrienn Mónika Szabó, Rita Kiss, József Németh, Béla Juhász, Zoltán Szilvássy,
and et al. 2020. "Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone" International Journal of Molecular Sciences 21, no. 6: 2124.
https://doi.org/10.3390/ijms21062124